New York, October 5th ( PRNewswire ) – Nationally renowned investor rights law firms Bronstein, Gewirtz & Grossman, LLC announced that they have filed a class action lawsuit against Anavex Life Sciences Corp (Nasdaq ticker: AVXL) and some of its executives.

This lawsuit is intended to represent all individuals and entities that purchased or otherwise acquired Anavex securities between November 26, 2025, and August 28, 2026 (including both dates), in order to recover losses incurred due to the defendant's alleged violations of federal securities laws. The law firm encourages interested investors to visit their website bgandg.com / cases / anavex-life-sciences-corp-avxl -class_action_lawsuit to learn more about the case and to join in.

Anavex Case Details

The indictment alleges that throughout the duration of the class action, the defendant made false and/or misleading statements, and/or failed to disclose the following facts:

• Anavex Lacks sufficient internal controls;
• Due to the improper behavior of the former CEO Christopher Missling, Anavex underestimated the potential regulatory challenges;
• Therefore, the defendant's statements regarding the business, operations, and prospects of Anavex were materially false and misleading at all relevant times, and/or lacked reasonable basis.

Anavex What should investors do next?

A class action has been filed. To view a copy of the complaint, please visit the law firm's website at bgandg.com / cases / anavex-life-sciences-corp-avxl -class_action_lawsuit; you may also contact the Peretz Bronstein lawyers or customer relationship managers at Bronstein , Gewirtz & Grossman , LLC , Nathan Miller, at telephone number 917-590-0911.

If you suffer losses on Anavex, you may request the court to appoint you as the lead plaintiff before November 30, 2026. Even if you do not serve as the lead plaintiff, you are still entitled to any potential compensation.

No upfront fees are charged to investors of Anavex.

Bronstein, Gewirtz & Grossman LLC indicate that they represent class-action investors on a contingency fee basis, meaning that the law firm will only request the court to reimburse its out-of-pocket expenses and attorney fees if they win the case, which is usually a certain percentage of the total amount recovered.

Why choose Bronstein, Gewirtz, Grossman, and LLC to act as proxies for the Anavex securities class action?

According to the firm, it is a nationally renowned agency specializing in class actions for securities fraud and derivative lawsuits on behalf of shareholders, having recovered hundreds of millions of dollars for investors across the United States. For more information, please refer to www.bgandg.com.

Bronstein, Gewirtz & Grossman, LLC founding partners. Peretz Bronstein stated: "The core of our business is to restore investors' capital and ensure corporate accountability, which helps to maintain the basic integrity of the market."

For updates, you can follow the law firm on LinkedIn, X, Facebook, or Instagram.

Contact Information

Peretz Bronstein Lawyers or Nathan Miller

Lawyer advertisement. Past results do not guarantee similar outcomes.